Serous tubal intraepithelial neoplasia: the concept and its application

Welcsh, 2001, BRCA1 and BRCA2 and the genetics of breast and ovarian cancer, Hum Mol Genet, 10, 705, 10.1093/hmg/10.7.705 Zweemer, 2000, Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations, Gynecol Oncol, 76, 45, 10.1006/gyno.1999.5623 Paley, 2001, Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis, Gynecol Oncol, 80, 176, 10.1006/gyno.2000.6071 Piek, 2001, Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J Pathol, 195, 451, 10.1002/path.1000 Cass, 2005, BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?, Obstet Gynecol, 106, 1327, 10.1097/01.AOG.0000187892.78392.3f Colgan, 2001, Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status, Am J Surg Pathol, 25, 1283, 10.1097/00000478-200110000-00009 Carcangiu, 2006, Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature, Am J Surg Pathol, 30, 1222, 10.1097/01.pas.0000202161.80739.ac Medeiros, 2006, The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome, Am J Surg Pathol, 30, 230, 10.1097/01.pas.0000180854.28831.77 Lee, 2007, A candidate precursor to serous carcinoma that originates in the distal fallopian tube [published erratum appears in: J Pathol 2007; 213:116], J Pathol, 211, 26, 10.1002/path.2091 Jarboe, 2008, Serous carcinogenesis in the fallopian tube: a descriptive classification, Int J Gynecol Pathol, 27, 1, 10.1097/pgp.0b013e31814b191f Gilks, 2015, Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas, Am J Surg Pathol, 39, 357, 10.1097/PAS.0000000000000353 Morrison, 2015, Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series, Am J Surg Pathol, 39, 442, 10.1097/PAS.0000000000000352 McAlpine, 2014, Ovarian Cancer Research Program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention, Am J Obstet Gynecol, 210, 471.e1, 10.1016/j.ajog.2014.01.003 Pauerstein, 1966, Cellular patterns in proliferative and anaplastic disease of the Fallopian tube, Am J Obstet Gynecol, 96, 486, 10.1016/S0002-9378(16)34686-5 Kindelberger, 2007, Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship, Am J Surg Pathol, 31, 161, 10.1097/01.pas.0000213335.40358.47 Przybycin, 2010, Are all pelvic (nonuterine) serous carcinomas of tubal origin?, Am J Surg Pathol, 34, 1407, 10.1097/PAS.0b013e3181ef7b16 Gilbert, 2012, Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project, Lancet Oncol, 13, 285, 10.1016/S1470-2045(11)70333-3 Conner, 2014, Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations, Gynecol Oncol, 132, 280, 10.1016/j.ygyno.2013.12.009 Vang, 2013, Fallopian tube precursors of ovarian low- and high-grade serous neoplasms, Histopathology, 62, 44, 10.1111/his.12046 Powell, 2011, Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol, Int J Gynecol Cancer, 21, 846, 10.1097/IGC.0b013e31821bc7e3 Bahar-Shany, 2014, Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma, Gynecol Oncol, 132, 322, 10.1016/j.ygyno.2013.12.015 George, 2012, Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status, Clin Cancer Res, 18, 6199, 10.1158/1078-0432.CCR-12-2155 Perets, 2013, Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models, Cancer Cell, 24, 751, 10.1016/j.ccr.2013.10.013 Bartlett, 2016, Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution, Nat Commun, 7, 11620, 10.1038/ncomms11620 Norquist, 2010, The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations, Cancer, 116, 5261, 10.1002/cncr.25439 Xian, 2010, The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube, J Pathol, 220, 17, 10.1002/path.2624 Kuhn, 2012, TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma—evidence supporting the clonal relationship of the two lesions, J Pathol, 226, 421, 10.1002/path.3023 Salvador, 2008, Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma, Gynecol Oncol, 110, 408, 10.1016/j.ygyno.2008.05.010 Kuhn, 2010, Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis, Am J Surg Pathol, 34, 829, 10.1097/PAS.0b013e3181dcede7 Yamamoto, 2016, In vitro in vivo correlates of physiological and neoplastic human Fallopian tube stem cells, J Pathol, 238, 519, 10.1002/path.4649 Chen, 2010, Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube, J Pathol, 222, 110, 10.1002/path.2739 Ning, 2014, The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium, J Pathol, 234, 478, 10.1002/path.4417 Quick, 2012, PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer, Mod Pathol, 25, 449, 10.1038/modpathol.2011.175 Li, 2013, Secretory cell expansion with aging: risk for pelvic serous carcinogenesis, Gynecol Oncol, 131, 555, 10.1016/j.ygyno.2013.09.018 Snegovskikh, 2014, Identification of putative fallopian tube stem cells, Reprod Sci, 21, 1460, 10.1177/1933719114553448 Seidman, 2016, Incidental serous tubal intraepithelial carcinoma and non-neoplastic conditions of the fallopian tubes in grossly normal adnexa: a clinicopathologic study of 388 completely embedded cases, Int J Gynecol Pathol, 35, 423, 10.1097/PGP.0000000000000267 Meserve, 2016, Detection of Serous Tubal Intraepithelial Carcinoma (STIC) in Incidentally removed fallopian tubes from low-risk women, Lab Invest, 297A McDaniel, 2015, Next-generation sequencing of tubal intraepithelial carcinomas, JAMA Oncol, 1, 1128, 10.1001/jamaoncol.2015.1618 Vang, 2012, Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma, Int J Gynecol Pathol, 31, 243, 10.1097/PGP.0b013e31823b8831 Jarboe, 2009, Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance, Int J Gynecol Pathol, 28, 308, 10.1097/PGP.0b013e3181934390 Rabban, 2015, Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia, Am J Surg Pathol, 39, 35, 10.1097/PAS.0000000000000293 Carlson, 2010, Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications, Int J Gynecol Pathol, 29, 310, 10.1097/PGP.0b013e3181c713a8 Rabban, 2009, Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol, Am J Surg Pathol, 33, 1878, 10.1097/PAS.0b013e3181bc6059 Deligdisch, 1999, Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations, Cancer, 86, 1544, 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I Auersperg, 2013, Front Biosci Schol Ed, 5, 709, 10.2741/S401 Dubeau, 1999, The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?, Gynecol Oncol, 72, 437, 10.1006/gyno.1998.5275 Banet, 2015, Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis, Int J Gynecol Pathol, 34, 3, 10.1097/PGP.0000000000000120 Kurman, 2011, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm, Hum Pathol, 42, 918, 10.1016/j.humpath.2011.03.003 Boyd, 2012, Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon, Am J Surg Pathol, 36, 368, 10.1097/PAS.0b013e31823732a9 Folkins, 2008, A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations, Gynecol Oncol, 109, 168, 10.1016/j.ygyno.2008.01.012 Hutson, 1995, p53 protein expression in putative precursor lesions of epithelial ovariancancer, Histopathology, 27, 367, 10.1111/j.1365-2559.1995.tb01528.x Pothuri, 2010, Genetic analysis of the early natural history of epithelial ovarian carcinoma, PLoS One, 5, e10358, 10.1371/journal.pone.0010358 Bell, 1994, Early de novo ovarian carcinoma. A study of fourteen cases, Cancer, 73, 1859, 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L Rabban, 2014, Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery, Am J Surg Pathol, 38, 729, 10.1097/PAS.0000000000000199 Ambros, 1995, Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation, Hum Pathol, 26, 1260, 10.1016/0046-8177(95)90203-1 Novak, 2015, Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma, Gynecol Oncol, 139, 104, 10.1016/j.ygyno.2015.07.100 Sehdev, 2010, Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase, Mod Pathol, 23, 844, 10.1038/modpathol.2010.60 Kuhn, 2012, The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma, Am J Surg Pathol, 36, 1826, 10.1097/PAS.0b013e31825ec07a Mehrad, 2010, A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube, Adv Anat Pathol, 17, 293, 10.1097/PAP.0b013e3181ecdee1 Berek, 2015, Cancer of the ovary, fallopian tube, and peritoneum, Int J Gynaecol Obstet, 131, S111, 10.1016/j.ijgo.2015.06.007 Singh, 2015, Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum, Histopathology, 67, 331, 10.1111/his.12651 Falconer, 2015, Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study, JNCI Journal of the National Cancer Institute, 107, dju410, 10.1093/jnci/dju410 American College of Obstetricians and Gynecologists: Committee Opinion. Salpingectomy for Ovarian Cancer Prevention Accessed on 22 February 2016. Available athttp://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Salpingectomy-for-Ovarian-Cancer-Prevention. Walker, 2015, Society of gynecologic oncology recommendations for the prevention of ovarian cancer, Cancer, 121, 2108, 10.1002/cncr.29321 Jacobs, 2016, Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial, Lancet, 387, 945, 10.1016/S0140-6736(15)01224-6 Harmsen, 2015, Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study, BMC Cancer, 15, 593, 10.1186/s12885-015-1597-y Roh, 2010, High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression, Mod Pathol, 23, 1316, 10.1038/modpathol.2010.119 Howitt, 2015, Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma, Am J Surg Pathol, 39, 287, 10.1097/PAS.0000000000000369 Ritterhouse, 2016, Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas, Mod Pathol, 29, 893, 10.1038/modpathol.2016.82